When was DermaSensor founded?

DermaSensor was founded in 2009 and raised its 1st funding round 9 years after it was founded.

Where is DermaSensor located?

DermaSensor is headquartered in Miami, United States.

How many employees does DermaSensor have?

As of Sep 30, 2026, the latest employee count at DermaSensor is 38.

Is DermaSensor a funded company?

DermaSensor is a funded company, having raised a total of $69.7M across 8 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 18, 2018.

When was the latest funding round of DermaSensor?

DermaSensor's latest funding was a $***** Series B round on Sep 09, 2026, with participation from 0 investor.

Where does DermaSensor rank among its competitors?

DermaSensor ranks 1st amongst 48 active competitors, of which 13 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was DermaSensor, which secured $4M in Sep, 2026.

Who are the top competitors of DermaSensor?

DermaSensor's top competitors include SciBase, Hememics Biotechnologies and Zerigo Health. Among them, DermaSensor secured the most recent funding round in September, 2026.

DermaSensor - 2026 Company Profile, Team, Funding & Competitors

DermaSensor is a series B company based in Miami (United States), founded in 2009 by Maurice R Ferre. It operates as a Developer of an AI-powered skin cancer detection device. DermaSensor has raised $69.7M in funding from SternAegis Ventures and Ceros Capital Markets. The company has 48 active competitors, including 13 funded and 4 that have exited. Its top competitors include companies like SciBase, Hememics Biotechnologies and Zerigo Health.

Company Details

Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.

Website: dermasensor.com
Social
Email ID: *****@dermasensor.com
Phone Number: +1 **********

Key Metrics

Founded Year

2009

Location

Miami, United States

Stage

Series B

Total Funding

$69.7M in 8 rounds

Latest Funding Round

Series B, Sep 09, 2026, $*****

Investors

SternAegis Ventures & 12 more

Ranked

1^st among 48 active competitors

Employee Count

38 as on Sep 30, 2026

Similar Companies

SciBase & 68 more

View DermaSensor's full profile

DermaSensor is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
DERMASENSOR, INC CIN: 270282657 , United States, Active	Dec 31, 1999	-	13 (As on Dec 31, 2024)	-

DermaSensor has raised a total funding of $69.7M over 8 rounds. Its first funding round was on Dec 18, 2018. DermaSensor has 11 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of DermaSensor:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 09, 2026	2948471	Series B	5702775	8213143	7926371	1393321
Jun 10, 2026	7194619	Series B	9965326	2241873	3796704	4332301
Oct 02, 2025	2640835	Series B	2498131	9398145	9801065	Pier 70 Ventures & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of DermaSensor's funding rounds and investors

The founders of DermaSensor is Maurice R Ferre.

Here are the details of DermaSensor's key team members:

Maurice R Ferre: Co-Founder of DermaSensor and founder of 2 other companies, DermaSensor and Fastrack Institute. They are also an angel investor in 1 startup.

View details of DermaSensor's Founder profiles and Board Members

DermaSensor's employee count trend

DermaSensor has 38 employees as of Sep 26. Here is DermaSensor's employee count trend over the years:

Uncover DermaSensor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DermaSensor include SciBase, Hememics Biotechnologies and Zerigo Health. Here is the list of Top 10 competitors of DermaSensor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DermaSensor 2009, Miami (United States), Series B	Developer of an AI-powered skin cancer detection device	$69.7M	Ceros Capital Markets, Neue Fund & 11 others	62/100
2nd	SciBase 1998, Stockholm (Sweden), Public	Provider of POC device for the detection of malignant melanoma	$22.3M	ÖstVäst Advisory AB, SEB & 5 others	61/100
3rd	Hememics Biotechnologies 2009, Gaithersburg (United States), Seed	Developer of techology platform for biopreservation	$4.6M	American Vietnamese Investment Partners, TEDCO ... & 2 others	51/100
4th	Zerigo Health 2014, San Diego (United States), Series B	Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema	$77.9M	7wire Ventures, Bluestem Capital & 16 others	45/100
5th	Anitoa Systems 2008, San Francisco (United States), Funding Raised	Provider of biosensors for diagnostic applications	-	COINX Group	44/100
6th	Roswell 2015, San Diego (United States), Series A	Provider of diagnostic sensor solutions for nucleic acid sequencing	$32M	JAM Fund, PTK Capital	42/100
7th	BIOGENES TECHNOLOGIES 2015, Kajang (Malaysia), Series A	Developing technology in molecular diagnostics and genomics	$5.7M	Antler, MOSTI & 5 others	41/100
8th	Biomensio 2015, Tampere (Finland), Seed	Provider of cloud-based biosensors for diagnostic applications	$2.65M	Siemens Technology Accelerator, EIC Fund & 6 others	36/100
9th	Creoptix 2009, Wadenswil (Switzerland), Acqui-Hired	Provider of web hosting, domain registration, and related support services	$15.1M	http://swisscanto.ch, EuroUS Ventures & 7 others	35/100
10th	AI Medical Technology 2020, Stockholm (Sweden), Seed	AI-powered diagnostic solutions for skin cancer detection	$1M	Northern Capsek Ventures, CVX Ventures	34/100